Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BIG Impact invests in autoimmune diagnostics and drug discovery startup AOI Biosciences

BIG Impact invests in autoimmune diagnostics and drug discovery startup AOI Biosciences

ReutersReuters2026/09/15 00:19
  • BIG Impact Inc completed an investment in AOI Biosciences, a Japan-based diagnostics and drug-discovery company focused on autoimmune diseases.
  • AOI Biosciences commercializes proprietary antibody testing with domestic and overseas medical institutions.
  • The company is building a drug-discovery platform using quantum-related technology, targeting autoimmune disease and infectious disease programs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIG Impact Inc published the original content used to generate this news brief on September 15, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!